Our Team

Helen Stevenson

Founder, President and CEO

Pre-Reformulary: In her former role as Assistant Deputy Minister of Health and Executive Officer of Ontario Public Drug Programs, Helen oversaw Ontario's $4 billion drug program. She led the most significant prescription drug reforms in two decades – Bill 102 – which saved Ontarians an unprecedented $1.5 billion over five years. Helen also led many of Ontario's drug system initiatives, including the Citizens' Council, Drugs for Rare Diseases Framework, MedsCheck, and the Ontario Narcotics Strategy. Helen is a Trustee of the Auto Sector Retiree Health Care Trust, a former Governor of the Board of North York General Hospital, and director of the Toronto East General Hospital Foundation.

Extra: Helen has a BCom (McGill University), MSM (Boston University Brussels), ICD.D. She has lived and worked in Belgium, Switzerland, and Canada.

Heather Nicol

Chief Financial Officer

Pre-Reformulary: Heather has diverse business experience in senior financial roles in the corporate sector, financial services and not for-profit. She was the CFO for Chapters Online, taking it public and helping it achieve national leadership. She advised Canadian Tire Corporation and economically restructured the financing of their stores. Her roles also include CFO for the MaRS Discovery District and EVP for an investment company specializing in pharmaceutical royalties. Earlier in her career, she worked in investment banking at TD Securities and Burns Fry Limited. Heather has been a member of several boards and currently sits on the board of Genworth MI Canada Inc. (TSX: MIC) as well as Genworth Financial Mortgage Insurance Company of Canada.

@Reformulary: Heather is the Chief Financial Officer at the Reformulary Group where she oversees financial and strategic matters including capital markets activities, planning and reporting.

Extra: She holds an Honours Bachelor of Mathematics from the University of Waterloo and a Master of Business Administration from the Ivey School at the University of Western Ontario. She is also a Certified Management Accountant, a Chartered Professional Accountant and has her ICD.D from the Institute of Corporate Directors.

Tom Zelenka

VP Analytics Solutions

Pre-Reformulary: Prior to joining Reformulary Group in September 2015, Tom had extensive experience in healthcare analytics, including THiNK and Abbott, among others. He was also a Senior Principal at IMS Consulting for seven years.

@Reformulary: Tom leads our Business Analytics area, working with clients to provide meaningful insights into pharmaceutical markets and healthcare behaviour.

Extra: Tom holds a BASc, Mech Eng from the University of Waterloo (highest academic standing award) and a Master of Business Administration from the Rotman School of Business at the University of Toronto.

Silvia Hruba

Formulary Coordinator

Pre-Reformulary: Silvia gained international biopharmaceutical experience as Office Manager at Pharm-In in Slovakia where she provided medical translation expertise in addition to more general executive level administrative support. Silvia was previously Convention Assistant at the Public Service Alliance of Canada where she coordinated an array of meetings and conventions, at the provincial level. Prior to that, she held various administrative positions within the Public Service Alliance of Canada.

@Reformulary: Silvia manages our drug database, including monitoring new drugs, provincial formularies, and manufacturers' submissions. Silvia is also an administrative coordinator for the Reformulary Expert Committee.

Extra: Silvia started her international career in Slovakia, and has lived and worked in England, the Netherlands and Canada. She is fluent in English and Slovak, and can hold conversations in French, Russian and Dutch.

Chakshu Shah

Business Analyst

Pre-Reformulary: Chakshu is a candidate for a combined BMath in Financial Analysis and Risk Management, and Computer Science degree from the University of Waterloo. Previously, as a co-op student, she had multiple work terms at Reformulary Group.

@Reformulary: Chakshu is one of the leads for our business analytics team, providing analytical support related to our Reformulary as well as in our IT initiatives, business development activities, and contract negotiations.

Amanda Belcham

Executive Assistant

Pre-Reformulary: She received her Honors Bachelor of Arts from the University of Toronto and her Bachelor of Education from the University of Ontario Institute of Technology. Through these years of university she has acquired a critical and analytical thought process that has been essential for the development of problem solving strategies.

Amanda provides administrative support for the Reformulary team, and dedicated scheduling support to the CEO.

Extra: Before joining the Reformulary Group in 2012, Amanda was a teacher for a private school system in Toronto.

Reformulary Expert Committee


Dr. Paul Oh

Paul is the Medical Director of the Cardiac Rehab and Secondary Prevention Program at the Toronto Rehabilitation Institute and Staff Physician in the Department of Medicine at Sunnybrook in Toronto.

Vice Chair

Dr. Muhammad Mamdani

Muhammad is the Director, Applied Health Research Centre (AHRC), Keenan Research Centre, Li Ka Shing Knowledge Institute of St. Michael's Hospital and an Associate Professor at the University of Toronto.

Special Advisors

Michael Boivin

Michael Boivin is a clinical pharmacist consultant, continuing education developer and president of CommPharm Consulting Inc.

Dr. Braden Manns

Braden is a nephrologist, an Associate Professor at the University of Calgary in the Departments of Medicine and Community Health Sciences and an Alberta Innovates – Health Solutions Health Scholar.

Dr. Joe Clarke

Joe Clarke is currently a Professor Emeritus of pediatrics at the University of Toronto. He obtained an M.D., a PhD in biochemistry and an M.Sc. in health policy. He has contributed to the basic understanding of a number of inherited metabolic diseases, including lysosomal storage diseases. For over 45 years, he maintained an active clinical practice attending patients of all ages affected with various inherited metabolic diseases. Dr. Clarke also wrote the textbook, A Clinical Guide to Inherited Metabolic Diseases, Cambridge University Press. 


Dr. Gerald A. Evans

Dr. Gerald Evans is the Chair of the Division of Infectious Diseases and a Professor in the Departments of Medicine, Biomedical & Molecular Sciences, and Pathology & Molecular Medicine at Queen's University and an attending physician in Infectious Diseases and Medical Director of Infection Prevention & Control at Kingston General Hospital. He is an Adjunct ICES Scientist and a co-investigator with the Ontario Drug Policy Research Network (ODPRN).

Dr. Michael Evans

Michael is an inner city physician at St Michael's Hospital, a scientist at the Li Ka Shing Knowledge Institute, and an Associate Professor in Family Medicine and Public Health at the University of Toronto. He is also the Director and Founder of the Health Design Lab, Toronto.

Jean Lachaine Ph.D.

Jean Lachaine is a professor at the Faculty of Pharmacy of the University of Montreal and is associate researcher at the Faculty of Medicine of the University of Montreal. He is a member of the Scientific Committee of the Quebec Institut National d'Excellence en Santé et en Services Sociaux (INESSS) as the expert in pharmacoeconomics. He is also an active member of the Quebec Network for Personalized Health Care and of the Personalized Medicine Partnership for Cancer (PMPC).  He is the owner of PeriPharm Inc, a company specialized in pharmacoeconomics and outcomes research.

Dr. Stuart MacLeod

Stuart has been Professor of Pediatrics at the University of British Columbia since 2003 and moved to emeritus status in January 2015.  He was Director of the Child and Family Research Institute at BC Children’s Hospital and served as Vice President Research for the Provincial Health Services Authority of British Columbia. His current research interests include pediatric clinical pharmacology and toxicology, adverse drug reactions, pharmacogenomics, drug policy and optimal drug use for children.

Dr. Elizabeth Mann

Elizabeth is a General Internist with special interest in cardiovascular diseases and porphyria. She was a Professor of Medicine at Dalhousie University. Elizabeth has received teaching and clinical awards from her department, the Canadian Society of Internal Medicine and the Royal College of Physicians and Surgeons of Canada. She has had a number of administrative roles and is currently Past President of the College of Physicians and Surgeons of Nova Scotia.

Dr. Peter Tugwell

Peter is a practicing rheumatologist at the Ottawa Hospital in Ottawa and a Professor of Medicine, and Epidemiology & Community Medicine at the University of Ottawa. He is also the Director for the Centre for Global Health under the Institute of Population Health at the University of Ottawa and the North American Editor of the Journal of Clinical Epidemiology.

Pharmacist Consultant

Sandra Knowles

Sandra Knowles is a Drug Information pharmacist at Sunnybrook Health Sciences Centre in Toronto and Assistant Professor (Status Only), Faculty of Pharmacy, University of Toronto. She has published extensively on adverse drug reactions in peer-reviewed journals and has contributed to various book chapters, with over 100 publications to date.